- Home
- BDRX vs UPC Comparison
BDRX vs UPC Comparison
Compare BDRX & UPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- UPC
- Stock Information
- Founded
- BDRX 2000
- UPC 1998
- Country
- BDRX United Kingdom
- UPC China
- Employees
- BDRX N/A
- UPC N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- UPC Biotechnology: Pharmaceutical Preparations
- Sector
- BDRX Health Care
- UPC Health Care
- Exchange
- BDRX Nasdaq
- UPC Nasdaq
- Market Cap
- BDRX 5.8M
- UPC 2.2M
- IPO Year
- BDRX N/A
- UPC 2021
- Fundamental
- Price
- BDRX $0.88
- UPC $3.59
- Analyst Decision
- BDRX
- UPC
- Analyst Count
- BDRX 0
- UPC 0
- Target Price
- BDRX N/A
- UPC N/A
- AVG Volume (30 Days)
- BDRX 3.1M
- UPC 21.7K
- Earning Date
- BDRX 04-11-2025
- UPC 07-18-2025
- Dividend Yield
- BDRX N/A
- UPC N/A
- EPS Growth
- BDRX N/A
- UPC N/A
- EPS
- BDRX N/A
- UPC N/A
- Revenue
- BDRX N/A
- UPC $19,293,003.00
- Revenue This Year
- BDRX N/A
- UPC N/A
- Revenue Next Year
- BDRX N/A
- UPC N/A
- P/E Ratio
- BDRX N/A
- UPC N/A
- Revenue Growth
- BDRX N/A
- UPC N/A
- 52 Week Low
- BDRX $0.78
- UPC $2.51
- 52 Week High
- BDRX $41.50
- UPC $2,592.00
- Technical
- Relative Strength Index (RSI)
- BDRX 38.47
- UPC 39.70
- Support Level
- BDRX $0.82
- UPC $3.54
- Resistance Level
- BDRX $0.90
- UPC $3.80
- Average True Range (ATR)
- BDRX 0.08
- UPC 0.20
- MACD
- BDRX 0.01
- UPC 0.01
- Stochastic Oscillator
- BDRX 12.26
- UPC 21.54
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About UPC Universe Pharmaceuticals Inc.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.